Delivery Order SPE2DB24D3013-SPE2DB25FFPED
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Gemtesa 75 mg tablets (90-count units) at a ceiling value of $2,378.33. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion on August 29, 2025, with performance to be executed at AmerisourceBergen's Conshohocken, Pennsylvania location. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $48,882.83 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count units) with a performance location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-asides and carries an ultimate completion date of August 18, 2025. This delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a $10,456.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Gemtesa 75 mg tablets (90-count units). The contract, which represents a non-competitive delivery order, is scheduled for completion by July 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award is a child delivery order executed under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $7,747.10 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90 count) on August 12, 2025, with completion scheduled for August 13, 2025. This competitively awarded, firm fixed price contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December...
- The Defense Logistics Agency awarded a $70,882.82 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90 count) on September 16, 2025, with an ultimate completion date of September 17, 2025. This non-competitive, non-set-aside contract is being performed at the vendor's Conshohocken, Pennsylvania location. The award represents a child delivery order issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $18,536.93 to AmerisourceBergen Drug Corp for 90-count supplies of Gemtesa 75 mg tablets. This firm fixed-price delivery order, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a competitively awarded, non-set-aside contract requiring performance in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $4,521.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count supply) with an ultimate completion date of July 17, 2025. This non-set-aside contract was competitively awarded on July 16, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $3,661.12 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count units) on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and is being performed at the vendor's Conshohocken, Pennsylvania location. As a child order under a larger contract vehicle, this delivery supports the federal government's pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $13,190.74 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price, non-set-aside contract is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $92,969.92 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count units) on September 3, 2025, with completion scheduled for September 4, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFPEDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,869.18 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (30-count supply) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price, competitively awarded contract involves no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. As the prime contractor under the DLA Troop Support Medical IDC, the company supplies a comprehensive range of pharmaceuticals and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare customers globally. This particular delivery order for Gemtesa, a medication used in urology treatment, exemplifies the company's role in fulfilling specialized pharmaceutical needs for federal health programs through flexible contract vehicles designed to ensure reliable medical supply chain support.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 8/8/25 |